Overview
Stephen Boorjian is an Urologist in Rochester, Minnesota. Dr. Boorjian is highly rated in 26 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Urothelial Cancer, Nephrectomy, and Cystectomy. Dr. Boorjian is currently accepting new patients.
His clinical research consists of co-authoring 480 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Medica
- Humana
Locations
Rochester, MN 55902
200 1st St Sw, Rochester, MN 55905
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Mayo Clinic
Matthew Tollefson is an Urologist in Rochester, Minnesota. Dr. Tollefson is highly rated in 14 conditions, according to our data. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy. Dr. Tollefson is currently accepting new patients.
Mayo Clinic
Bradley Leibovich is an Urologist in Rochester, Minnesota. Dr. Leibovich is highly rated in 18 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Nephrectomy, and Thrombectomy. Dr. Leibovich is currently accepting new patients.
Mayo Clinic
Igor Frank is an Urologist in Rochester, Minnesota. Dr. Frank is highly rated in 13 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Frank is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Chromophobe Renal Cell Carcinoma
- Familial Prostate Cancer
- Hydronephrosis
- Upper Tract Urothelial Carcinoma (UTUC)
- WT1-Related Wilms Tumor Syndromes
- Advanced
- Clear Cell Sarcoma
- Familial Wilms Tumor 2
- Horseshoe Kidney
- Lymphadenectomy
- Non-Muscle Invasive Bladder Cancer
- Penectomy
- Experienced
- Bilateral Hydronephrosis
- Boils
- Carbuncle
- Chylous Ascites
- Empyema
- End-Stage Renal Disease (ESRD)